A worthwhile re-post by mordicai.....
As to the price, well consider this. This stock was trading the first couple months of this year 1 to 1.5 cents. That was before orphan drug approval, nigerian license, sales, the nigerian loan, chassman infusion of more capital.. Yet people are now hesitant to pony up 2.2 cents for the shares? As I said before this company has some ignorant shareholders.